Evidence map›Paper›PMID 19144136›Full record

ArticleRetrovirology2009

Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo.

Nico Michel, Christine Goffinet, Kerstin Ganter, Ina Allespach, Vineet N Kewalramani, Mohammed Saifuddin, Dan R Littman, Warner C Greene, Mark A Goldsmith, Oliver T Keppler

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. The wide utility of rabbits as models of human diseases.Experimental & molecular medicine · 2018
    Review
  2. Review
  3. Article
  4. Article
  5. Retroviral restriction and dependency factors in primates and carnivores.Veterinary immunology and immunopathology · 2011
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Nico MichelDepartment of Virology, University of Heidelberg, 69120 Heidelberg, Germany. mail@nicomichel.de
Christine Goffinet
Kerstin Ganter
Ina Allespach
Vineet N Kewalramani
Mohammed Saifuddin
Dan R Littman
Warner C Greene
Mark A Goldsmith
Oliver T Keppler
Heidelberg University · DEGladstone Institutes · USHoward Hughes Medical Institute · USEastern Virginia Medical School · USUniversity of California, San Francisco · US

Funding

Microglia and the Neuropathogenesis of HIV DiseaseR01MH064396 · NIMH · J. DAVID GLADSTONE INSTITUTES · PI GREENE, WARNER C · 2002 to 2006
$2.2M
TRANSGENIC RATS FOR THE STUDY OF HIV DISEASER21AI046258 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI KEPPLER, OLIVER T · 1999 to 2001
$534k
Howard Hughes Medical InstituteNIAID NIH HHS R21-AI46258NIMH NIH HHS R01 MH064396NIMH NIH HHS R01-MH64396
6 · The paper itself

Abstract

backgroundCells derived from native rodents have limits at distinct steps of HIV replication. Rat primary CD4 T-cells, but not macrophages, display a profound transcriptional deficit that is ameliorated by transient trans-complementation with the human Tat-interacting protein Cyclin T1 (hCycT1).

resultsHere, we generated transgenic rats that selectively express hCycT1 in CD4 T-cells and macrophages. hCycT1 expression in rat T-cells boosted early HIV gene expression to levels approaching those in infected primary human T-cells. hCycT1 expression was necessary, but not sufficient, to enhance HIV transcription in T-cells from individual transgenic animals, indicating that endogenous cellular factors are critical co-regulators of HIV gene expression in rats. T-cells from hCD4/hCCR5/hCycT1-transgenic rats did not support productive infection of prototypic wild-type R5 HIV-1 strains ex vivo, suggesting one or more significant limitation in the late phase of the replication cycle in this primary rodent cell type. Remarkably, we identify a replication-competent HIV-1 GFP reporter strain (R7/3 YU-2 Env) that displays characteristics of a spreading, primarily cell-to-cell-mediated infection in primary T-cells from hCD4/hCCR5-transgenic rats. Moreover, the replication of this recombinant HIV-1 strain was significantly enhanced by hCycT1 transgenesis. The viral determinants of this so far unique replicative ability are currently unknown.

conclusionThus, hCycT1 expression is beneficial to de novo HIV infection in a transgenic rat model, but additional genetic manipulations of the host or virus are required to achieve full permissivity.

Indexed as

Transcription, GeneticVirus ReplicationAnimalsCD4-Positive T-LymphocytesCells, CulturedCyclinsCyclin THIV-1HumansMacrophagesRatsRats, TransgenicCCNT1 protein, humanCyclinsCyclin T

Identifiers

PMID19144136
PMCPMC2631513
OpenAlexW2080415772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.